Avantor Past Earnings Performance
Past criteria checks 1/6
Avantor has been growing earnings at an average annual rate of 52.6%, while the Life Sciences industry saw earnings growing at 19.1% annually. Revenues have been growing at an average rate of 4.7% per year. Avantor's return on equity is 4.9%, and it has net margins of 3.8%.
Key information
52.6%
Earnings growth rate
65.2%
EPS growth rate
| Life Sciences Industry Growth | 20.2% |
| Revenue growth rate | 4.7% |
| Return on equity | 4.9% |
| Net Margin | 3.8% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Avantor makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 6,867 | 260 | 1,497 | 0 |
| 31 Dec 23 | 6,967 | 321 | 1,466 | 0 |
| 30 Sep 23 | 7,039 | 364 | 1,470 | 0 |
| 30 Jun 23 | 7,176 | 423 | 1,475 | 0 |
| 31 Mar 23 | 7,342 | 610 | 1,469 | 0 |
| 31 Dec 22 | 7,512 | 662 | 1,457 | 0 |
| 30 Sep 22 | 7,625 | 598 | 1,442 | 0 |
| 30 Jun 22 | 7,603 | 572 | 1,445 | 0 |
| 31 Mar 22 | 7,551 | 534 | 1,463 | 0 |
| 31 Dec 21 | 7,386 | 508 | 1,426 | 0 |
| 30 Sep 21 | 7,269 | 466 | 1,442 | 0 |
| 30 Jun 21 | 7,040 | 267 | 1,388 | 0 |
| 31 Mar 21 | 6,660 | 169 | 1,345 | 0 |
| 31 Dec 20 | 6,394 | 52 | 1,342 | 0 |
| 30 Sep 20 | 6,127 | 71 | 1,336 | 0 |
| 30 Jun 20 | 6,026 | 135 | 1,332 | 0 |
| 31 Mar 20 | 6,079 | -226 | 1,334 | 0 |
| 31 Dec 19 | 6,040 | -335 | 1,329 | 0 |
| 30 Sep 19 | 5,990 | -514 | 1,294 | 0 |
| 30 Jun 19 | 5,981 | -554 | 1,303 | 0 |
| 31 Mar 19 | 5,926 | -330 | 1,305 | 0 |
| 31 Dec 18 | 5,864 | -356 | 1,321 | 0 |
| 30 Sep 18 | 5,120 | -639 | 1,215 | 0 |
| 31 Dec 17 | 1,247 | -415 | 376 | 0 |
| 31 Dec 16 | 691 | -42 | 257 | 0 |
| 31 Dec 15 | 637 | 22 | 185 | 0 |
Quality Earnings: AVTR has a large one-off loss of $194.4M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: AVTR's current net profit margins (3.8%) are lower than last year (8.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AVTR has become profitable over the past 5 years, growing earnings by 52.6% per year.
Accelerating Growth: AVTR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AVTR had negative earnings growth (-57.3%) over the past year, making it difficult to compare to the Life Sciences industry average (6.5%).
Return on Equity
High ROE: AVTR's Return on Equity (4.9%) is considered low.